ArticleMedicine2026
Genetically predicted ZDHHC8 expression and osteoporosis risk: A two-sample Mendelian randomization and metabolite mediation study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein S-palmitoylation regulates protein localization, stability, and signaling and has emerging roles in bone-cell biology. We investigated whether genetically predicted expression of palmitoylation-related genes is associated with osteoporosis risk and explored circulating metabolites as candidate mediators. We performed a 2-sample Mendelian randomization (MR) study using cis-expression quantitative trait locus instruments for 22 palmitoylation-related genes, FinnGen R10 osteoporosis data (8017 cases and 391,037 controls), and 1400 circulating metabolite traits (1091 metabolites and 309 metabolite ratios). Inverse-variance weighted was the primary estimator. Weighted-median and MR-Egger analyses, Cochran Q testing, and instrument-strength assessment were used as sensitivity analyses. Summary-data-based MR with the heterogeneity in dependent instruments test was used as an additional gene expression validation. Gene Expression Omnibus bone marrow mesenchymal stem cell datasets were used for expression comparison; GSE35959 was treated as the SuperSeries containing GSE35956 and GSE35958 rather than as an independent replication cohort. Two-step MR and the product-of-coefficients approach were used to estimate candidate mediation effects. Genetically predicted zinc finger DHHC-type palmitoyltransferase 8 (ZDHHC8) expression was associated with higher osteoporosis risk (odds ratio = 1.23, 95% confidence interval: 1.09-1.39, P = .0007), and the association met the Bonferroni threshold for the 22-gene screen. Summary-data-based MR provided additional, nominal evidence for ZDHHC8 (P = .0415). ZDHHC8 expression was higher in osteoporosis-derived bone marrow mesenchymal stem cells in the Gene Expression Omnibus comparison. Three metabolite traits: 3-(3-amino-3-carboxypropyl)uridine (acp3U), 2-hydroxyhippurate, and X-25343, showed directionally coherent 2-step MR estimates, with estimated mediated proportions of 11%, 9%, and 10%, respectively. Because these metabolite findings did not meet a Bonferroni threshold for 1400 tests, they are interpreted as exploratory candidate mediators. Genetically predicted ZDHHC8 expression is associated with osteoporosis risk across complementary genetic and expression analyses. The metabolite results suggest possible intermediate pathways but remain hypothesis-generating. These findings support further functional study of ZDHHC8 in bone cells rather than immediate clinical targeting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.